Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GetGoal-O: Lixisenatide in Older T2D Patients
NCT01798706Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2013
- Primary completion
- Feb 2015
- Modality
- Peptides
- Countries
- 13
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jun 2013; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01798706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798706.